Sustainability & Climate

A revolutionary, non-toxic wood treatment is entering the market, promising to make homes safer from wildfires and disrupt a billion-dollar industry.

A major foundation is investing $75.8M to build a responsible public architecture for AI, funding projects that prioritize human rights and global equity.

With a $60M backing from a mystery investor, U Power plans to bring its AI-driven battery swapping tech to Southern Europe. Can it succeed?

Falco Resources restructures key debt and names a new board chair, gaining critical runway to advance its massive Horne 5 gold project in Quebec.

Southchip posts its 11th straight quarter of revenue growth, but falling margins and a huge R&D spend reveal a bold, high-risk expansion strategy.

Zephyrus Innovations just got FDA clearance for VaporShield, a device protecting nurses from drug exposure. It’s a story of safety, market disruption, and efficiency.

Vantage's recent triple award win for trust, tech, and social good is more than a trophy. It reveals the new anatomy of a broker's identity.

A breakthrough clinical trial and a savvy financial move could net Fractyl Health $18M to advance its novel obesity treatment beyond the GLP-1 boom.

Biotech Immunome plans a massive stock offering. A deep dive into the high-stakes bet on its cancer pipeline and what it means for investors.

A $1.2M investment isn't just charity; it's a strategic push for 'whole-person health' aimed at fixing the Pacific Northwest's deepest care gaps.

Ford hits the brakes on its aggressive EV plan, pivoting to profitable hybrids and a bold new venture in battery energy storage. What does this mean?

Kodiak Sciences is raising crucial capital with a stock offering, diluting investors but fueling its late-stage retinal drugs. Is this a necessary lifeline or a red flag?

Verastem Oncology taps industry heavyweights for its leadership, signaling a bold new strategy to accelerate its cancer pipeline and grow its market share.

Tiziana's CEO doubles down with a major share purchase, signaling deep faith in a novel MS drug, even as market signals send mixed messages.

A popular countertop choice is fueling a deadly, incurable lung disease among workers, sparking a public health crisis and a race for safer alternatives.

An ISG report names Rackspace a leader in AI-driven cloud services, revealing how it helps midmarket firms master cost, complexity, and security.

One firm is ditching market predictions for a new approach: debunking costly myths. Here’s why this matters for healthcare leaders and investors.

AECOM's win on the GSA OASIS+ contract is more than a deal; it's a strategic move reshaping federal services and securing its role in national projects.

With a key hire and a market set to hit $1.1T, Suffolk is positioning itself to lead the construction industry's seismic shift to integrated design-build.

The agtech unicorn is poaching top talent from industry giants. This strategic move signals an aggressive push for global dominance in sustainable agriculture.